RGEN FY 2012 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2012 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$62M+128.2% YoY

Gross Profit

$35M56.4% margin

Operating Income

$11M17.8% margin

Net Income

$14M22.7% margin

EPS (Diluted)

$0.45

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$12M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$97M

Total Liabilities

$13M

Stockholders' Equity

$84M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62M	$27M	+128.2%
Gross Profit	$35M	$20M	+74.0%
Operating Income	$11M	-$374,071	+3062.8%
Net Income	$14M	-$43,509	+32635.9%